Displaced intra-articular calcaneal fracture (DIACF)
Conditions
Interventions
Patients in the group will be treated with a computer-controlled cooling brace. The control group will receive a pressure bandage without cooling.
Sponsors
Erasmus MC, University Medical Center Rotterdam, Trauma Research Unit, Department of Surgery
Erasmus Medical Center, Medical Research Ethics Committee (MREC)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a displaced (>2 mm step-off in posterior facet), intra-articular calcaneal fracture (Sanders type II-IV or OTA type 82C2-4) 2. Indication for ORIF using an extended lateral approach 3. Adult men or women aged 18 years or older 4. Hospital presentation within two days after trauma* 5. Provision of informed consent by patient
Exclusion criteria
Exclusion criteria: 1. Patients with an existing condition that result in asymmetrical morphometric characteristics of the distal part of either one of the lower legs 2. Additional traumatic injuries that might influence extremity volume (e.g., lower extremity fracture, pelvic fracture) 3. Patients with bilateral calcaneal fractures 4. Patients with a pathological, recurrent, or open calcaneal fracture 5. Patients with decreased sensory function in any leg that might affect pain sensation. 6. Patients not fit for surgery 7. Patients unwilling or unable to comply with the intervention or follow-up visit schedule 8. Insufficient comprehension of Dutch or English language to understand rehabilitation programs and other treatment information in the judgment of the attending physician 9. Participation in another surgical intervention or drug study that might influence any of the outcome parameters
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Preoperative and postoperative pain; Preoperative and postoperative swelling; Preoperative and postoperative foot/ankle circumference; Postoperative hospital length of stay; Satisfaction with the approach to reduce swelling; Adverse events within three months after surgery. | — |
Contacts
Public ContactJack J.M. Dekker
Arkin
Outcome results
None listed